February 2024

2 Minutes
Medicine

PharmaKure Announces Collaboration with Sheffield Hallam University

PharmaKure, a clinical stage pharmaceutical company developing precision medicines for Alzheimer’s Disease (AD) and other neurodegenerative diseases, have announced a new epigenetics collaboration with Sheffield Hallam University. This partnership will focus on ‘gene-based environmental biomarkers’, known...
Read More